Organovo (NASDAQ:ONVO) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Organovo (NASDAQ:ONVO) in a research report report published on Saturday. The firm issued a sell rating on the medical research company’s stock.

Organovo Stock Up 2.1 %

Shares of NASDAQ:ONVO opened at $0.39 on Friday. The business has a 50 day moving average price of $0.38 and a 200 day moving average price of $0.45. Organovo has a twelve month low of $0.32 and a twelve month high of $1.74. The company has a market cap of $5.93 million, a price-to-earnings ratio of -0.36 and a beta of 0.54.

About Organovo

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.